SIONNA THERAPEUTICS, INC. Shareholders' Equity
SIONNA THERAPEUTICS, INC. (SION) had Shareholders' Equity of $265.77 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $265.77M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $288.21M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $306.83M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $321.67M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $265.77M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $288.21M 10-Q · filed 2026-08-06 |
| 2025-12-31 | $306.83M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $321.67M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $336.43M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $351.77M 10-Q · filed 2026-08-06 |
| 2024-12-31 | -$163.71M 10-Q · filed 2026-08-06 |
| 2024-09-30 | -$148.55M 10-Q · filed 2025-11-05 |
| 2024-06-30 | -$133.77M 10-Q · filed 2025-11-05 |
| 2024-03-31 | -$126.08M 10-Q · filed 2025-11-05 |
| 2023-12-31 | -$114.88M 10-K · filed 2026-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |